Could an allergy pill help heal the brain in MS? new trial aims to find out
NCT ID NCT06065670
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether clemastine fumarate, an over-the-counter allergy medication, can repair damaged nerve insulation (myelin) in people with multiple sclerosis. About 44 adults with relapsing-remitting MS will receive either the drug or a placebo for 3 months, then all will get the drug for 3 more months. Researchers will use special MRI scans to measure myelin repair in the brain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICALLY ISOLATED SYNDROME, CNS DEMYELINATING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sandler Neurosciences Building, Neurological Clinical Research Unit
San Francisco, California, 94107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden MS progression: can brain scans and blood tests predict it?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Can a new MRI scan reveal the Brain's hidden repair process in MS?
- Walking workouts may sharpen the MS brain — a trial puts it to the test
- Can a simple obstacle course reveal hidden links between fatigue and walking trouble in MS?
- Can sensing wrist position unlock better hand control in MS?